These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10546223)

  • 1. [Immunogenic properties of albeferon--biologically active artificial protein].
    Afasizheva IIu; Dolgikh DA; Kirpichnikov MP
    Mol Biol (Mosk); 1999; 33(4):679-83. PubMed ID: 10546223
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of a biologically active interferon fragment on the structure of the synthetic protein carrier].
    Afasizheva IIu; Dolgikh DA; Abdullaev ZKh; Latypov RF; Tiktopulo EI; Uverskiĭ VN; Ptitsyn OB; Kirpichnikov MP
    Biofizika; 1998; 43(3):384-91. PubMed ID: 9702328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Artificial proteins with a given spatial structure and biological activity].
    Dolgikh DA; Gabriélian AE; Navolotskaia EV; Chemeris VV; Kirpichnikov MP
    Biofizika; 1993; 38(1):67-74. PubMed ID: 8471646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Introduction of biologically active fragments of interferon-alpha2 and insulin into the artificial protein albebetin affects immunogenicity of the final construct].
    Bocharova OV; Moshkovskiĭ SA; Chertikova RV; Abdullaev ZKh; Kolesanova EF; Dolgikh DA; Kirpichnikov MP
    Vopr Med Khim; 2002; 48(1):94-102. PubMed ID: 12068502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering by homologous recombination: exploring sequence and function within a conserved fold.
    Carbone MN; Arnold FH
    Curr Opin Struct Biol; 2007 Aug; 17(4):454-9. PubMed ID: 17884462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An activity-independent selection system of thermostable protein variants.
    Chautard H; Blas-Galindo E; Menguy T; Grand'Moursel L; Cava F; Berenguer J; Delcourt M
    Nat Methods; 2007 Nov; 4(11):919-21. PubMed ID: 17906633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein engineering of interferon alphas.
    Hu R; Lei KJ; Bekisz J; Zoon KC
    Methods Mol Med; 2005; 116():69-80. PubMed ID: 16000855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of two-state to multi-state folding kinetics on fusion of two protein foldons.
    Inaba K; Kobayashi N; Fersht AR
    J Mol Biol; 2000 Sep; 302(1):219-33. PubMed ID: 10964571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential protein assembly on micropatterned surfaces with tailored molecular and surface multivalency.
    Valiokas R; Klenkar G; Tinazli A; Tampé R; Liedberg B; Piehler J
    Chembiochem; 2006 Sep; 7(9):1325-9. PubMed ID: 16888732
    [No Abstract]   [Full Text] [Related]  

  • 10. Alpha interferon is a powerful adjuvant for a recombinant protein vaccine against foot-and-mouth disease virus in swine, and an effective stimulus of in vivo immune response.
    Cheng G; Zhao X; Yan W; Wang W; Zuo X; Huang K; Liu Y; Chen J; Wang J; Cong W; Liu M; Gao H; Chen J; Lu Y; Zheng Z
    Vaccine; 2007 Jul; 25(28):5199-208. PubMed ID: 17555848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linkers for improved cleavage of fusion proteins with an engineered alpha-lytic protease.
    Lien S; Milner SJ; Graham LD; Wallace JC; Francis GL
    Biotechnol Bioeng; 2001 Aug; 74(4):335-43. PubMed ID: 11410858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering allosteric protein switches by domain insertion.
    Ostermeier M
    Protein Eng Des Sel; 2005 Aug; 18(8):359-64. PubMed ID: 16043448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformation-specific affinity purification of proteins using engineered binding proteins: application to the estrogen receptor.
    Huang J; Koide A; Nettle KW; Greene GL; Koide S
    Protein Expr Purif; 2006 Jun; 47(2):348-54. PubMed ID: 16325424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathway of oxidative folding of bovine alpha-interferon: predominance of native disulfide-bonded folding intermediates.
    Lin CC; Chang JY
    Biochemistry; 2007 Mar; 46(12):3925-32. PubMed ID: 17328561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knotted fusion proteins reveal unexpected possibilities in protein folding.
    Mallam AL; Onuoha SC; Grossmann JG; Jackson SE
    Mol Cell; 2008 Jun; 30(5):642-8. PubMed ID: 18538662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme stabilization by domain insertion into a thermophilic protein.
    Kim CS; Pierre B; Ostermeier M; Looger LL; Kim JR
    Protein Eng Des Sel; 2009 Oct; 22(10):615-23. PubMed ID: 19622545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assistance of maltose binding protein to the in vivo folding of the disulfide-rich C-terminal fragment from Plasmodium falciparum merozoite surface protein 1 expressed in Escherichia coli.
    Planson AG; Guijarro JI; Goldberg ME; Chaffotte AF
    Biochemistry; 2003 Nov; 42(45):13202-11. PubMed ID: 14609331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of segment substitution on the structure and stability of immunoglobulin G binding domain of streptococcal protein G.
    Du HN; Zhang TY; Chang YG; Lin DH; Hu HY
    Biopolymers; 2005 Sep; 79(1):9-17. PubMed ID: 15838890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of interferon-alpha 2 in therapy: structural and physiological aspects.
    Kontsek P; Liptáková H; Kontseková E
    Acta Virol; 1999 Feb; 43(1):63-70. PubMed ID: 10672347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The de novo protein with grafted biological function: transferring of interferon blast-transforming activity to albebetin.
    Dolgikh DA; Uversky VN; Gabrielian AE; Chemeris VV; Federov AN; Navolotskaya EV; Zav'yalov VP; Kirpichnikov MP
    Protein Eng; 1996 Feb; 9(2):195-201. PubMed ID: 9005441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.